NASDAQ:ADPT | Free Cash Flow | Adaptive Biotechnologies Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9.54M$796,000.00-$10.33M
2025-12-31$2.06M$636,000.00$1.42M
2025-03-31-$28.48M$1.26M-$29.74M
2024-12-31-$12.49M$80,000.00-$12.57M
2024-03-31-$38.35M$1.51M-$39.86M
2023-12-31-$26.93M$1.3M-$28.23M
2023-03-31-$59.15M$2.92M-$62.08M
2022-12-31-$30.02M$2.54M-$32.56M
2022-03-31-$64.45M$3.08M-$67.53M
2021-12-31-$53.83M$9.25M-$63.07M
2021-03-31-$58.25M$15.84M-$74.09M
2020-12-31-$39.84M$9.37M-$49.21M
2020-03-31-$31.61M$2.96M-$34.57M
2019-12-31-$26.79M$2.42M-$29.21M
2019-03-31$278.3M$3.83M$274.47M
2018-12-31-$5.41M$2.5M-$7.91M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$45.99M$2.96M-$48.95M
2024-12-31-$95.21M$3.66M-$98.88M
2023-12-31-$156.32M$10.7M-$167.02M
2022-12-31-$183.95M$16.35M-$200.29M
2021-12-31-$192.73M$61.75M-$254.47M
2020-12-31-$149.68M$18.8M-$168.49M
2019-12-31$205.4M$11.2M$194.2M
2018-12-31-$32.26M$6.3M-$38.56M
2017-12-31-$34.86M$2.42M-$37.28M